127 related articles for article (PubMed ID: 2449348)
1. Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis.
Webberley JM; Matthews RS; Andrews JM; Wise R
Eur J Clin Microbiol; 1987 Oct; 6(5):587-9. PubMed ID: 2449348
[TBL] [Abstract][Full Text] [Related]
2. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis].
Korting HC; Hartinger A
Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain.
How SJ; Hobson D; Hart CA; Quayle E
J Antimicrob Chemother; 1985 Apr; 15(4):399-404. PubMed ID: 3891709
[TBL] [Abstract][Full Text] [Related]
4. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of tetracycline & ciprofloxacin against Chlamydia trachomatis isolates from conjunctivitis patients.
Madhavan HN; Roy S; Malathy J
Indian J Med Res; 1996 Mar; 103():138-41. PubMed ID: 9062038
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Samra Z; Rosenberg S; Soffer Y; Dan M
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):177-9. PubMed ID: 11337185
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
Welsh LE; Gaydos CA; Quinn TC
Antimicrob Agents Chemother; 1992 Feb; 36(2):291-4. PubMed ID: 1318677
[TBL] [Abstract][Full Text] [Related]
8. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.
Lee CK; Bowie WR; Alexander ER
Antimicrob Agents Chemother; 1978 Mar; 13(3):441-5. PubMed ID: 162541
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
Walsh M; Kappus EW; Quinn TC
Antimicrob Agents Chemother; 1987 May; 31(5):811-2. PubMed ID: 3038010
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugs.
Cevenini R; Donati M; Sambri V; Rumpianesi F; La Placa M
J Antimicrob Chemother; 1987 Nov; 20(5):677-84. PubMed ID: 3323161
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).
Lefèvre JC; Lépargneur JP
Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of fleroxacin against Chlamydia trachomatis.
Steele-Mortimer O; Meier-Ewert H
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
[TBL] [Abstract][Full Text] [Related]
14. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
Bailey JM; Heppleston C; Richmond SJ
Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
[TBL] [Abstract][Full Text] [Related]
18. Minimum inhibitory and minimal lethal concentration against Chlamydia trachomatis dependent on the time of addition and the duration of the presence of antibiotics.
Notomi T; Ikeda Y; Nagayama A
Chemotherapy; 1999; 45(4):242-8. PubMed ID: 10394006
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
Busolo F; Conventi L
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Sensitivity Profile of Chlamydia trachomatis isolates from Croatia in McCoy Cell Culture System and Comparison with the Literature.
Mestrović T; Ljubin-Sternak S; Sviben M; Bedenić B; Vranes J; Markotić A; Skerk V
Clin Lab; 2016; 62(3):357-64. PubMed ID: 27156324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]